COVID-19 R&D: Pharma’s Path Ahead
Global research and development for preventative vaccines and therapeutics to treat COVID-19 have progressed at a rapid pace. Still, key issues remain and to the dampen the effects of virus in 2022, even greater collaboration is needed.
You may also be interested in...
Recent executive changes in the industry include the appointment of a new Chief Medical Officer at Caribou Biosciences and promotions at Exicure. Meanwhile, H-Cyte Inc., among other companies, has chosen new independent directors.
It is time for In Vivo's 14th annual Deals of the Year contest. We've selected 15 nominees across three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.